| | Variables | MACE () | Non-MACE () | | |
| | Age (years) | 74 (67,80) | 64 (56,71) | 10.445 | | | Male, (%) | 118 (56.46) | 763 (72.32) | 20.784 | | | Hypertension, (%) | 150 (71.77) | 707 (67.01) | 1.807 | 0.179 | | Diabetes mellitus, (%) | 99 (47.37) | 325 (30.80) | 27.331 | | | Stroke, (%) | 69 (33.01) | 223 (21.13) | 13.852 | | | Current smokers, N (%) | 96 (45.93) | 641 (60.76) | 15.772 | | | Previous MI, (%) | 56(26.79) | 185(17.53) | 9.691 | 0.002 | | Previous PCI, (%) | 40 (19.14) | 170 (16.11) | 1.152 | 0.283 | | Previous CABG, (%) | 16 (7.66) | 55 (5.21) | 1.963 | 0.161 | | GRACE scores (points) | | | | | | ≤108, (%) | 17 (8.13) | 355 (33.65) | 54.681 | | | 109–140, (%) | 57 (27.27) | 426 (40.38) | 12.692 | | | >140, (%) | 135 (64.59) | 274 (25.97) | 118.88 | | | LVEF (%) | 55 (48,59) | 45 (37,55) | −8.312 | | | Serum creatinine(μmol/L) | 93.0 (75.0, 113.0) | 78.0 (67.0, 94.0) | 6.737 | | | NT-proBNP (pg/mL) | 3338.0 (1107.0, 8993.5) | 753.7 (329.0, 1766.5) | 11.995 | | | Hs-cTnT (ng/mL) | 0.9 (0.4, 2.1) | 0.5 (0.2, 1.1) | 6.143 | | | Treatment methods | | | | | | Conservative treatment, (%) | 101 (48.33) | 335 (31.75) | 21.202 | | | PCI, (%) | 87 (41.63) | 623 (59.05) | 21.515 | | | CABG, (%) | 21 (10.05) | 97 (9.19) | 0.150 | 0.698 | | Extent of coronary artery disease, (%) | | | | | | 0-Vessel, (%) | 2 (0.96) | 18 (1.71) | 0.629 | 0.428 | | 1-Vessel, (%) | 10 (4.78) | 156 (14.78) | 15.297 | | | 2-Vessel, (%) | 35 (16.75) | 194 (18.39) | 0.317 | 0.573 | | 3-Vessel, (%) | 91 (43.54) | 490 (46.45) | 0.593 | 0.441 | | LM disease, (%) | 117 (55.98) | 36 (3.41) | 453.10 | | | ≥1 vessel occlusion, (%) | 78 (37.32) | 354 (33.55) | 1.100 | 0.294 |
|
|
